Mar 2, 2026 by Prosper Junior BakinyBuying This 1 Pharmaceutical Stock Today Could Make You a Multimillionaire RetireeThis stock looks unstoppable right now.
Mar 2, 2026 by Adria CiminoCoreWeave: After Dropping 18%, Is It a Stock to Avoid or Once-in-a-Decade Buying Opportunity?Investors frowned on one point in the latest earnings report.
Mar 2, 2026 by Motley Fool StaffPayPal Buyout RumorsThe market is buzzing with rumors of companies interested in buying Paypal. We look into whether there's fire behind the smoke.
Mar 2, 2026 by Kailey Hagen, CFPTrying to Get the $5,251 Max Social Security Benefit Is Overrated. Do This Instead.The max benefit is out of reach for most people, but these things aren't.
Mar 2, 2026 by Leo SunCould Investing $10,000 in Circle (CRCL) Stock Make You a Millionaire?This stablecoin stock still has a bright future.
Mar 2, 2026 by Rich SmithWhy Planet Labs Stock Popped TodayPlanet Labs stock is in the right place, at the right time. (But is the price right?)
Mar 2, 2026 by Matt DiLalloWant $1 Million In Retirement? Invest $100 a Month in These 3 Stocks and Don't Look Back.These companies have excellent records of enriching investors.
Mar 2, 2026 by Motley Fool StaffUnexpected Stock Picks and Looking to the FutureWhy does the shortest month of the year sometimes feel like the longest?
Mar 2, 2026 by Jake LerchInvestment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC FilingThis clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach.
Mar 2, 2026 by Ryan Vanzo2 Nuclear Energy Stocks to Buy in MarchOklo and NuScale Power continue to attract nuclear investors.
Mar 2, 2026 by Jake LerchInvestment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC FilingThis clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.
Mar 2, 2026 by Selena Maranjian1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never SellThe reason is so compelling that I actually did buy the stock -- and I have no plans to sell.
Mar 2, 2026 by Dan CaplingerThis ETF Has Delivered Massive Returns for 33 Years -- And It's Just Hitting Its StrideFor some investors, you can't improve on the original.
Mar 2, 2026 by Josh Kohn-LindquistWhy Turning Point Brands Stock Is Plummeting TodayTurning Point's pivot to white nicotine pouches is going well, but is temporarily weighing on the company's profitability.
Mar 2, 2026 by Jonathan PoncianoMercadoLibre Hits $14.5 Billion Sales as New $829 Million Position SurfacesMercadoLibre operates a leading e-commerce and fintech platform serving consumers and businesses across Latin America.
Mar 2, 2026 by David Jagielski, CPAUnitedHealth's Stock Might Not Rally Until This Number ImprovesThe company's rising costs are a big reason investors have been dumping the stock of late.
Mar 2, 2026 by David Jagielski, CPAUp Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock?Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.
Mar 2, 2026 by David Jagielski, CPAIs CRISPR Therapeutics Stock Too Risky to Buy Right Now?CRISPR isn't profitable, but it does have an approved gene therapy treatment with loads of potential.
Mar 2, 2026 by Lawrence NgaWhere Could Duolingo Be in 3 Years?Will it be a durable AI-powered subscription platform, or a mature consumer app facing new competitive pressures?
Mar 2, 2026 by David Jagielski, CPAWhy AbbVie Stock May Be the Ultimate Option for Dividend InvestorsAbbVie pays a high dividend, has grown its payout regularly, and has a strong underlying business.
